JP2024507638A - 性機能障害処置のための神経刺激性ステロイドの使用 - Google Patents
性機能障害処置のための神経刺激性ステロイドの使用 Download PDFInfo
- Publication number
- JP2024507638A JP2024507638A JP2023540524A JP2023540524A JP2024507638A JP 2024507638 A JP2024507638 A JP 2024507638A JP 2023540524 A JP2023540524 A JP 2023540524A JP 2023540524 A JP2023540524 A JP 2023540524A JP 2024507638 A JP2024507638 A JP 2024507638A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutically acceptable
- acceptable salt
- administered
- sexual
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026066979A JP2026120717A (ja) | 2021-01-28 | 2026-04-15 | 性機能障害処置のための神経刺激性ステロイドの使用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163142840P | 2021-01-28 | 2021-01-28 | |
| US202163142833P | 2021-01-28 | 2021-01-28 | |
| US63/142,840 | 2021-01-28 | ||
| US63/142,833 | 2021-01-28 | ||
| PCT/US2022/014075 WO2022165017A1 (en) | 2021-01-28 | 2022-01-27 | Use of neuroactive steroids for treatment of sexual dysfunction |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026066979A Division JP2026120717A (ja) | 2021-01-28 | 2026-04-15 | 性機能障害処置のための神経刺激性ステロイドの使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024507638A true JP2024507638A (ja) | 2024-02-21 |
| JP2024507638A5 JP2024507638A5 (cg-RX-API-DMAC7.html) | 2025-02-03 |
Family
ID=80787167
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023540524A Pending JP2024507638A (ja) | 2021-01-28 | 2022-01-27 | 性機能障害処置のための神経刺激性ステロイドの使用 |
| JP2026066979A Pending JP2026120717A (ja) | 2021-01-28 | 2026-04-15 | 性機能障害処置のための神経刺激性ステロイドの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026066979A Pending JP2026120717A (ja) | 2021-01-28 | 2026-04-15 | 性機能障害処置のための神経刺激性ステロイドの使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240122945A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4284382A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2024507638A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230136599A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022214187A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3206537A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL304080A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023008726A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022165017A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS62761B1 (sr) | 2012-08-21 | 2022-01-31 | Sage Therapeutics Inc | Alopregnanolon za lečenje refraktornog epileptičkog statusa |
| SMT202100509T1 (it) | 2013-04-17 | 2021-11-12 | Sage Therapeutics Inc | Steroide di c21-n-pirazolile 19-nor c3,3-disostituito per l'uso in terapia |
| US10246482B2 (en) | 2014-06-18 | 2019-04-02 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| JOP20200195A1 (ar) | 2014-09-08 | 2017-06-16 | Sage Therapeutics Inc | سترويدات وتركيبات نشطة عصبياً، واستخداماتها |
| WO2016082789A1 (en) | 2014-11-27 | 2016-06-02 | Sage Therapeutics, Inc. | Compositions and methods for treating cns disorders |
| WO2018013613A1 (en) | 2016-07-11 | 2018-01-18 | Sage Therapeutics, Inc. | C17, c20, and c21 substituted neuroactive steroids and their methods of use |
| TW202604538A (zh) | 2016-08-23 | 2026-02-01 | 美商賽吉醫療公司 | 結晶19-去甲c3,3-二取代之c21-n-吡唑類固醇 |
| US20200291059A1 (en) | 2017-12-08 | 2020-09-17 | Sage Therapeutics, Inc. | Compositions and methods for treating cns disorders |
| IL309922A (en) * | 2021-07-28 | 2024-03-01 | Sage Therapeutics Inc | Crystalline forms of a neuroactive steroid |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016535796A (ja) * | 2013-11-11 | 2016-11-17 | ユーシミクス・バイオサイエンス・インコーポレイテッドEuthymics Bioscience,Inc. | 新規な方法 |
| JP2017516793A (ja) * | 2014-05-29 | 2017-06-22 | セージ セラピューティクス, インコーポレイテッド | 神経刺激性ステロイド、組成物、およびその使用 |
| JP2019511488A (ja) * | 2016-03-08 | 2019-04-25 | セージ セラピューティクス, インコーポレイテッド | 神経刺激性ステロイド、組成物、およびその使用 |
| WO2019241442A1 (en) * | 2018-06-12 | 2019-12-19 | Sage Therapeutics, Inc. | A 19-nor c3,3-disubstituted c21 -n-pyrazolyl steroid and methods of use thereof |
| WO2020180955A1 (en) * | 2019-03-04 | 2020-09-10 | Praxis Precision Medicines, Inc. | Methods for the treatment of perimenopause and menopause |
| WO2021252314A1 (en) * | 2020-06-08 | 2021-12-16 | Eliem Therapeutics, Inc. | Methods of treating female health conditions related to sex hormones |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20080080094A (ko) * | 2005-10-14 | 2008-09-02 | 하. 룬트벡 아크티에 셀스카브 | 에스시탈로프람 및 부프로피온의 저용량 조합물을 이용한중추신경계 장애의 치료 방법 |
| SMT202100509T1 (it) | 2013-04-17 | 2021-11-12 | Sage Therapeutics Inc | Steroide di c21-n-pirazolile 19-nor c3,3-disostituito per l'uso in terapia |
| TW202604538A (zh) | 2016-08-23 | 2026-02-01 | 美商賽吉醫療公司 | 結晶19-去甲c3,3-二取代之c21-n-吡唑類固醇 |
| EP3612186A1 (en) * | 2017-04-18 | 2020-02-26 | Marinus Pharmaceuticals, Inc. | Sustained release injectable neurosteroid formulations |
-
2022
- 2022-01-27 WO PCT/US2022/014075 patent/WO2022165017A1/en not_active Ceased
- 2022-01-27 EP EP22704661.2A patent/EP4284382A1/en active Pending
- 2022-01-27 IL IL304080A patent/IL304080A/en unknown
- 2022-01-27 US US18/263,189 patent/US20240122945A1/en active Pending
- 2022-01-27 KR KR1020237025051A patent/KR20230136599A/ko active Pending
- 2022-01-27 JP JP2023540524A patent/JP2024507638A/ja active Pending
- 2022-01-27 CA CA3206537A patent/CA3206537A1/en active Pending
- 2022-01-27 MX MX2023008726A patent/MX2023008726A/es unknown
- 2022-01-27 AU AU2022214187A patent/AU2022214187A1/en active Pending
-
2026
- 2026-04-15 JP JP2026066979A patent/JP2026120717A/ja active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016535796A (ja) * | 2013-11-11 | 2016-11-17 | ユーシミクス・バイオサイエンス・インコーポレイテッドEuthymics Bioscience,Inc. | 新規な方法 |
| JP2017516793A (ja) * | 2014-05-29 | 2017-06-22 | セージ セラピューティクス, インコーポレイテッド | 神経刺激性ステロイド、組成物、およびその使用 |
| JP2019511488A (ja) * | 2016-03-08 | 2019-04-25 | セージ セラピューティクス, インコーポレイテッド | 神経刺激性ステロイド、組成物、およびその使用 |
| WO2019241442A1 (en) * | 2018-06-12 | 2019-12-19 | Sage Therapeutics, Inc. | A 19-nor c3,3-disubstituted c21 -n-pyrazolyl steroid and methods of use thereof |
| WO2020180955A1 (en) * | 2019-03-04 | 2020-09-10 | Praxis Precision Medicines, Inc. | Methods for the treatment of perimenopause and menopause |
| WO2021252314A1 (en) * | 2020-06-08 | 2021-12-16 | Eliem Therapeutics, Inc. | Methods of treating female health conditions related to sex hormones |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2026120717A (ja) | 2026-07-22 |
| EP4284382A1 (en) | 2023-12-06 |
| CA3206537A1 (en) | 2022-08-04 |
| MX2023008726A (es) | 2023-12-14 |
| US20240122945A1 (en) | 2024-04-18 |
| KR20230136599A (ko) | 2023-09-26 |
| WO2022165017A1 (en) | 2022-08-04 |
| AU2022214187A9 (en) | 2024-05-23 |
| IL304080A (en) | 2023-08-01 |
| AU2022214187A1 (en) | 2023-07-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240122945A1 (en) | Use of neuroactive steroids for treatment of sexual dysfunction | |
| WO2022177718A1 (en) | Use of neuroactive steroid for treatment of sexual dysfunction | |
| US8309535B2 (en) | Compositions and methods to treat recurrent medical conditions | |
| CN114712356A (zh) | 用于治疗抑郁症的右美沙芬和安非他酮的组合 | |
| TWI638654B (zh) | 用以治療中樞神經系統疾病之包含苯甲酸鹽化合物及鞣酸的組合物 | |
| KR20170068480A (ko) | 다발성 경화증의 치료를 위한 시포니모드 및 라퀴니모드를 포함하는 조합물 | |
| WO2001017521A1 (en) | Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction | |
| JP2024050575A (ja) | L-4-クロロキヌレニンの治療的使用 | |
| TWI387452B (zh) | 用於治療性功能障礙之方法 | |
| JP2024516297A5 (cg-RX-API-DMAC7.html) | ||
| JP2024503114A (ja) | 神経精神疾患に対する抗うつ剤とデキストロメトルファンとの組み合わせ | |
| JPH09501664A (ja) | 神経変性疾病におけるフルピルチンの一次及び二次神経保護作用 | |
| WO2001034172A2 (en) | Methods and compositions for treating reward deficiency syndrome | |
| JP2022552808A (ja) | Gaba-a受容体陽性アロステリック調節因子と、nmda拮抗薬、nmda陰性アロステリック調節因子、またはnmda部分作動薬との組み合わせ | |
| CN116847852A (zh) | 神经活性类固醇治疗性功能障碍的用途 | |
| CZ2004739A3 (cs) | Použití desoxypeganinu k ošetřování klinické deprese | |
| WO2022235576A1 (en) | Methods and compositions for treating depression | |
| US20140148465A1 (en) | Compositions and Methods to Improve Treatment of Medical Conditions Using D-Cycloserine | |
| JP7579027B2 (ja) | セスキテルペンラクトン系化合物の視神経炎治療薬の製造における使用 | |
| MXPA01001178A (es) | Metodos y composiciones para tratamiento y la prevencion de ciertos trastornos psiquiatricos y medicos mediante el empleo de la moclobemida. | |
| JP2008513430A (ja) | 月経前症候群および月経前不快気分障害の処置のためのピンドロール | |
| HK40100385A (en) | Combination of an antidepressant and dextromethorphan for neuropsychiatric conditions | |
| MX2014002965A (es) | Combinaciones que comprenden un modulador del receptor de s1p. | |
| SEINER et al. | 15 Psychopharmacology and Neurotherapeutics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250124 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20250124 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20251211 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20251217 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20260310 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260415 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20260803 |